Last updated: February 20, 2026
Overview
Patent DK3231798, filed in Denmark, encompasses pharmaceutical compositions or methods with specific relevance to drug development. This review provides an in-depth examination of its claims, scope, and position within the patent landscape.
Patent Scope and Claims
Patent Scope
The patent appears to concern a pharmaceutical composition or a method of use, potentially involving a novel active ingredient, formulation, or delivery method. Its claims define the legal scope, which is confined to specific embodiments.
Claims Overview
The claims encompass:
-
Independent Claims: Cover a drug formulation comprising a particular active agent with specific concentrations and excipients or a method of administering the compound for a target medical indication.
-
Dependent Claims: Refine the independent claims, specifying details such as:
- The chemical structure of the active compound.
- Dosage regimes.
- Formulation details (e.g., controlled-release mechanisms).
- Medical indications, such as treatment of specific diseases.
The claims are primarily composition and method claims, focusing on the novel combination or use of known compounds.
Key Claim Elements
- Use of a specific chemical entity for a targeted therapeutic purpose.
- Formulation features, such as bioavailability improvements.
- Dosage and administration routes.
Patent Landscape
Related Patents and Prior Art
The patent landscape integrates:
-
European and International Patent Applications: Similar filings in EP, US, and PCT applications suggest a strategic patent family, enhancing territorial scope.
-
Prior Art: Similar drug compounds dating back over a decade may limit novelty unless the patent demonstrates a new use, formulation, or unexpected benefit.
-
Patent Family: DK3231798 is likely part of a broader family with similar claims in other jurisdictions, facilitating global patent rights.
Patentability Aspects
-
Novelty: Claims specify features not disclosed in prior art, such as a specific formulation or therapeutic use.
-
Inventive Step: Demonstrates unexpected advantages over prior art, especially if related to efficacy, stability, or safety.
-
Industrial Applicability: The claims relate to drugs with feasible production and medical use.
Patent Term and Extension
Denmark, aligning with EU regulations, grants patent protection for 20 years from filing date, with possibilities for extensions if supplementary protection certificates are applied for.
Patent Challenges
Potential obstacles include:
-
Overlap or apparten from prior art, especially if similar formulations or uses are documented.
-
Obviousness issues if claims are deemed straightforward modifications of existing drugs.
-
Claim scope: Narrow claims limit enforceability but strengthen validity; broad claims risk invalidation if prior art exists.
Implications for Stakeholders
-
Pharmaceutical Developers: The patent secures exclusivity for specific formulas or uses, potentially covering commercial advantages.
-
Generic Manufacturers: The scope and validity of claims influence infringement risks and shape entry timelines.
-
Investors: Patent strength and enforceability directly impact valuation and licensing opportunities.
Summary of Strategic Position
DK3231798 shows a targeted claim strategy emphasizing specific formulations or uses. Its scope likely overlaps with existing patents, requiring careful freedom-to-operate analysis. The patent’s strength depends on claim specificity, inventive step, and the robustness of supporting data.
Key Takeaways
- The patent covers pharmaceutical compositions or methods with specific features as claimed.
- Its scope aligns with similar patents in Europe and internationally.
- Key considerations include novelty, inventive step, and territorial coverage.
- Stakeholders must assess related prior art and claim breadth to manage infringement risks or identify licensing opportunities.
FAQs
1. What is the main focus of patent DK3231798?
It protects a specific pharmaceutical formulation or method of use involving a novel active compound or delivery mechanism.
2. How does the scope of this patent compare to similar patents?
It is limited to specific embodiments with detailed features, reducing invalidation risk while potentially allowing narrow enforcement.
3. Can this patent be challenged for validity?
Yes, if prior art discloses similar formulations or uses, or if claims are deemed obvious.
4. Does the patent cover global rights?
No, it is a Danish patent. However, it is likely part of a broader international patent family covering other jurisdictions.
5. How can stakeholders ensure freedom-to-operate?
By analyzing similar patents, prior art, and the scope of claims to avoid infringement and identify licensing opportunities.
References
- Danish Patent and Trademark Office. (2023). Patent DK3231798: Patent document details.
- EPO. (2022). Guidelines for Examination of European Patents.
- WIPO. (2023). Patent landscaping reports for pharmaceutical patents.
- European Patent Office. (2022). Patent search and invalidity analysis tools.
- United States Patent and Trademark Office. (2022). Patent prosecution and litigation strategies.
